KRTAP5-4
gene geneOn this page
Also known as KRTAP5.4
Summary
KRTAP5-4 (keratin associated protein 5-4, HGNC:23599) is a protein-coding gene on chromosome 11p15.5, encoding Keratin-associated protein 5-4 (Q6L8H1). In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linki….
Predicted to be located in cytosol.
Source: NCBI Gene 387267 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 16 total
- MANE Select transcript:
NM_001347674
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23599 |
| Approved symbol | KRTAP5-4 |
| Name | keratin associated protein 5-4 |
| Location | 11p15.5 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KRTAP5.4 |
| Ensembl gene | ENSG00000241598 |
| Ensembl biotype | protein_coding |
| Entrez | 387267 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000399682
RefSeq mRNA: 1 — MANE Select: NM_001347674
NM_001347674
CCDS: CCDS86161
Canonical transcript exons
ENST00000399682 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001539611 | 1620958 | 1622138 |
Expression profiles
Bgee: expression breadth broad, 19 present calls, max score 40.34.
Top tissues by expression
107 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skin of leg | UBERON:0001511 | 40.34 | gold quality |
| zone of skin | UBERON:0000014 | 39.68 | gold quality |
| skin of abdomen | UBERON:0001416 | 39.15 | gold quality |
| bone marrow cell | CL:0002092 | 38.14 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 37.50 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| gall bladder | UBERON:0002110 | 36.60 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.31 | gold quality |
| primary visual cortex | UBERON:0002436 | 34.99 | silver quality |
| prefrontal cortex | UBERON:0000451 | 34.69 | silver quality |
| muscle tissue | UBERON:0002385 | 33.74 | gold quality |
| cerebellum | UBERON:0002037 | 33.64 | gold quality |
| cerebellar cortex | UBERON:0002129 | 33.53 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 33.37 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 33.21 | gold quality |
| bone marrow | UBERON:0002371 | 32.76 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 32.35 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| lymph node | UBERON:0000029 | 31.76 | silver quality |
| leukocyte | CL:0000738 | 31.44 | gold quality |
| monocyte | CL:0000576 | 31.26 | gold quality |
| vermiform appendix | UBERON:0001154 | 30.31 | silver quality |
| endocervix | UBERON:0000458 | 30.11 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| placenta | UBERON:0001987 | 27.78 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 27.77 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.22 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (1): KRTAP5-3 (ENSG00000196224)
Protein
Protein identifiers
Keratin-associated protein 5-4 — Q6L8H1 (reviewed: Q6L8H1)
Alternative names: Keratin-associated protein 5.4, Ultrahigh sulfur keratin-associated protein 5.4
All UniProt accessions (1): A8MUN0
UniProt curated annotations — full annotation on UniProt →
Function. In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins.
Subunit / interactions. Interacts with hair keratins.
Tissue specificity. Restricted to hair root, not detected in any other tissues.
Similarity. Belongs to the KRTAP type 5 family.
RefSeq proteins (1): NP_001334603* (*=MANE)
Domains & families (InterPro)
UniProt features (11 total): repeat 9, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6L8H1-F1 | 45.39 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6805567 | Keratinization |
MSigDB gene sets: 14 (showing top):
MARTINEZ_RB1_TARGETS_DN, GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, GOCC_SUPRAMOLECULAR_COMPLEX, GOCC_POLYMERIC_CYTOSKELETAL_FIBER, REACTOME_KERATINIZATION, GOCC_SUPRAMOLECULAR_POLYMER, MARTINEZ_RB1_AND_TP53_TARGETS_DN, WP_VITAMIN_D_RECEPTOR_PATHWAY, GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN, MARTINEZ_TP53_TARGETS_DN, GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN, GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN, chr11p15
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): cytosol (GO:0005829), intermediate filament (GO:0005882)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
| intermediate filament cytoskeleton | 1 |
| polymeric cytoskeletal fiber | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
127 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HOXA1 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.600 |
| LCE5A | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.600 |
| KRTAP5-4 | OTX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | GLRX3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTX1 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE2C | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GLRX3 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CYSRT1 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NOTCH2NLC | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1D | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-8 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-1 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-9 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | KRTAP9-3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | CRCT1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP1-3 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POU4F2 | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3B | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | KRTAP5-2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | CATSPER1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1B | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE3C | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | KRTAP11-1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LCE1C | KRTAP5-4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP5-4 | PLEKHF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (62): KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid), KRTAP5-4 (Two-hybrid)
ESM2 similar proteins: A0A286YEV6, A0A286YEX9, A0A286YF01, A0A286YF60, A0A286YF77, A0A286YFB4, A0A286YFG1, C0J7L8, O08884, P04459, P18165, P26371, P26372, Q01644, Q02957, Q02958, Q3LI54, Q3LI58, Q3LI59, Q3LI61, Q3LI63, Q3LI64, Q3LI66, Q3LI67, Q3LI70, Q3LI72, Q3SYF9, Q62220, Q64507, Q6L8G5, Q6L8H1, Q6L8H2, Q6L8H4, Q701N2, Q701N4, Q7Z4W3, Q8C1I6, Q8IUB9, Q925H2, Q925H3
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 37 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 19 | 36.5× | 3e-25 |
| Formation of the cornified envelope | 11 | 33.3× | 2e-13 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| keratinization | 11 | 92.0× | 1e-17 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
16 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
421 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:1621858:C:A | donor_gain | 0.9600 |
| 11:1621884:G:C | donor_gain | 0.9500 |
| 11:1621853:AGCCC:A | donor_gain | 0.9100 |
| 11:1622070:T:TA | donor_gain | 0.8900 |
| 11:1621853:AGCC:A | donor_gain | 0.8600 |
| 11:1621209:T:C | acceptor_gain | 0.8300 |
| 11:1621222:T:C | acceptor_gain | 0.8200 |
| 11:1622067:G:GA | donor_gain | 0.7900 |
| 11:1621853:AGC:A | donor_gain | 0.7800 |
| 11:1622066:AG:A | donor_gain | 0.7800 |
| 11:1621879:C:CT | donor_gain | 0.7700 |
| 11:1621642:CAGC:C | acceptor_gain | 0.7600 |
| 11:1621882:CAG:C | donor_gain | 0.7600 |
| 11:1621222:T:TC | acceptor_gain | 0.7400 |
| 11:1621832:TGGA:T | donor_gain | 0.7400 |
| 11:1621209:T:TC | acceptor_gain | 0.7100 |
| 11:1621853:AG:A | donor_gain | 0.7100 |
| 11:1621646:C:CC | acceptor_gain | 0.6700 |
| 11:1621417:CA:C | donor_gain | 0.6600 |
| 11:1620982:C:CT | acceptor_gain | 0.6400 |
| 11:1621647:T:G | acceptor_loss | 0.6400 |
| 11:1621911:G:C | donor_gain | 0.6400 |
| 11:1621680:C:CC | acceptor_gain | 0.6200 |
| 11:1621839:C:CA | donor_gain | 0.6200 |
| 11:1621143:CT:C | acceptor_gain | 0.6100 |
| 11:1621828:C:A | donor_gain | 0.6100 |
| 11:1621854:G:C | donor_gain | 0.6100 |
| 11:1621865:AGCC:A | donor_gain | 0.6100 |
| 11:1621909:CAGCA:C | donor_gain | 0.6100 |
| 11:1621870:C:T | donor_gain | 0.6000 |
AlphaMissense
1462 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1002216026 (11:1623471 T>C,G), RS1003213810 (11:1623523 G>A), RS1004262125 (11:1623031 G>A), RS1004489764 (11:1622903 T>C), RS1004998507 (11:1624018 C>T), RS1006907532 (11:1621319 C>G), RS1007353803 (11:1620976 C>T), RS1008358930 (11:1622777 A>T), RS1008428479 (11:1623854 T>C), RS1010013370 (11:1622401 G>A), RS1010311350 (11:1622701 G>A), RS1010892750 (11:1622459 A>G), RS1011276798 (11:1623534 G>A), RS1012411160 (11:1622362 C>A,T), RS1012691502 (11:1623057 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.